Eribulin solution for injection 0.44 mg/ml vial 2 ml | 3 ml

Oncolytics

Eribulin is a cancer medicine that works by stopping cancer cells from growing and spreading.

It is used in adults to treat locally advanced or metastatic breast cancer (breast cancer that has spread beyond the original tumour) when at least one other treatment has been tried but is no longer effective.

It is also used in adults to treat advanced or metastatic liposarcoma (a type of cancer that starts in fatty tissue) when previous treatment has been tried but is no longer effective.

A full description of the effectiveness and possible side effects of this medicine can be found in the patient information leaflet and summary of product characteristics.

Want to do some fact checking? Send an e-mail or call us for more information.

contact

Want to do some fact checking? Send an e-mail or call us for more information.

contact

Want to do some fact checking? Send an e-mail or call us for more information.

contact

Subscribe to ournewsletter

Please sign up for our newsletter. Stay informed about the latest updates and our medicines, services, and innovations. After signing up, we will send a confirmation of your registration upon approval..

Subscribe to our newsletter

Please sign up for our newsletter. Stay informed about the latest updates and our medicines, services, and innovations. After signing up, we will send a confirmation of your registration upon approval..

Subscribe to our newsletter

Please sign up for our newsletter. Stay informed about the latest updates and our medicines, services, and innovations. After signing up, we will send a confirmation of your registration upon approval..